HealthPhoto: Hindu BusinessDr. Reddy’s Gets US FDA Tentative Approval for HIV Drug Lenacapavir
Dr. Reddy’s Laboratories has received tentative approval from the US FDA for its twice-yearly injectable HIV prevention drug, lenacapavir, under the PEPFAR program. The drug targets pre-exposure prophylaxis to reduce sexually acquired HIV-1 risk in adults and adolescents. Initial supplies are expected by December, with wider rollout planned for 2027. The approval follows voluntary licensing and partnerships to support development and access.
Hindu Business··Hyderabad




